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San Francisco, California 
Clinical expressions of myocardial ischemia are protean and 
include angina and symptoms related to ventricular systolic 
and diastolic dysfunction and arrhythmia. The consequences 
of ischemia are also variable and range from no immediate 
adverse effects to sudden death, myocardial infarction and 
severe impairment of cardiac performance and heart failure. 
However, myocardial ischemia can occur without any clin- 
ical manifestations and can be clinically totally silent. There 
is a multitude of evidence for the existence of “silent” 
myocardial ischemia (1). 
Reversible left ventricular regional wall motion abnormal- 
ities, either stress-induced or spontaneous, in the absence of 
angina, provide evidence for silent myocardial ischemia. 
Global and regional myocardial lactate production, a meta- 
bolic marker of ischemia, has been documented in the 
absence of angina. Reversible myocardial thallium perfusion 
defects at rest or during dipyridamole or exercise stress 
occur rather frequently without associated angina. On the 
basis of wall motion abnormalities, metabolic dysfunction, 
reversible scintigraphic perfusion defects and ischemic 
changes on the stress electrocardiogram (ECG), the inci- 
dence rate of silent myocardial ischemia has been estimated 
to be approximately 34% in patients with coronary artery 
disease (2). 
However, recently popularized ambulatory electrocar- 
diography in studies to detect ischemia have revealed a 
much higher incidence of silent ischemia (3). It has been 
documented that ST segment shifts, both depression and 
elevation. on the ambulatory ECG correlate well with other 
markers of myocardial ischemia (4). Electrocardiographic 
monitoring has revealed that in patients with stable exer- 
tional angina resulting from obstructive coronary artery 
disease, approximately 70% of episodes of ischemia are 
asymptomatic. In postinfarction patients and in patients with 
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mixed angina, a similar, higher incidence of asymptomatic 
ST segment shifts has been reported (5,6). 
Present study. In this issue of the Journal, Langer et al. 
(7) report the frequency, anatomic correlates and signifi- 
cance of symptomatic and asymptomatic ST segment shifts 
in patients with unstable angina. Of 135 patients reported, 89 
(66%) had ST shifts on Holter monitor and the majority 
(68%) of these 89 patients had only silent ischemia. In only 
6% of patients were ST shifts always symptomatic, and in 
the remaining 26% of patients both symptomatic and asymp- 
tomatic ST shifts occurred. As reported in other studies (2- 
6), this study also indicates that silent ischemia typically 
occurs in patients with established coronary artery disease, 
and the majority of the episodes of ischemia are not accom- 
panied by angina. Indeed, in this study, 92% of the episodes 
of ST shift were asymptomatic and only 8% were symp- 
tomatic. 
Mechanisms of silent ischemia. Although it appears to be 
established that silent myocardial ischemia is frequent in 
patient with coronary artery disease, its pathophysiologic 
mechanisms and significance are beginning to be clarified. 
Myocardial ischemia results from the imbalance between 
myocardial oxygen requirements and oxygen supply. An 
increase in the determinants of myocardial oxygen demand 
may precipitate myocardial ischemia if the oxygen require- 
ments outstrip the capacity to increase coronary blood flow. 
In patients with exertional angina with predictable and 
relatively fixed exercise threshold, increased oxygen re- 
quirement is believed to be the principal mechanism for 
angina during exercise. The mechanism for asymptomatic 
ischemia (e.g., ST shift or reversible thallium perfusion 
defects during exercise tests) in these patients is also likely 
to be similar. 
During pacing-induced myocardial ischemia, symptom- 
atic or asymptomatic, there is an inadequate increase in 
coronary blood flow to balance the increase in heart rate- 
blood pressure product (8). However. in patients with 
chronic stable angina, asymptomatic episodes of ischemia 
detected during Holter ECG monitoring may occur without 
any significant change in heart rate; similarly, symptomatic 
ST shifts during Holter monitoring also occur with little or 
no change in heart rate (4). Selwyn et al. (9) observed that an 
increase in heart rate of >lO beatslmin preceding the onset 
of the ST shift in the ambulatory ECG occurred only during 
20% of episodes of ischemia. Transient myocardial perfusion 
defects detected by positron emission tomography with or 
without angina also occurred in many instances without any 
significant increase in heart rate (4.9). These findings suggest 
that a primary reduction in coronary blood flow rather than 
an increase in oxygen requirements is the principal mecha- 
nism for these ischemic episodes. and the mechanism is 
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similar whether ischemia is manifest or silent. In patients 
with variant angina, reduction of coronary blood flow result- 
ing from segmental spasm of the epicardial coronary arteries 
appears to induce both symptomatic and asymptomatic 
spontaneous ischemia (10). 
Mechanisms of silent ischemia in unstable angina. In the 
present study reported by Langer et al. (7), the incidence of 
multivessel coronary artery disease and left main coronary 
artery stenosis was much higher in patients with asymptom- 
atic ST shifts on Holter monitoring. Although it is not clear 
from this study whether both symptomatic and asymptom- 
atic ST shifts were associated with a similar incidence of 
multivessel disease, previous studies (11) have reported a 
high incidence of multivessel and left main coronary artery 
disease in patients with unstable angina. Thus, both manifest 
and silent myocardial ischemia in patients with unstable 
angina are associated with similar anatomic correlates-i.e., 
presence of multivessel coronary artery disease. The mech- 
anisms for spontaneous ischemia in patients with “unstable 
angina,” whether manifest or silent, also appear to be 
similar. In this study by Langer et al. (7), there was a slight 
but significant increase in rate-pressure product 10 min 
before onset of both symptomatic and asymptomatic ST 
shifts. These findings suggest that increased myocardial 
oxygen requirements might have been contributory in pre- 
cipitating ischemia. It needs to be emphasized, however, 
that the magnitude of increase in rate-pressure product 
preceding ischemia was relatively small. 
Furthermore, a fair proportion of the episodes of ST 
shifts occurred without any prior change or even decrease in 
rate-pressure product. Thus, a primary reduction or an 
inadequate increase in coronary blood flow must be consid- 
ered as a potential mechanism for myocardial ischemia in 
these patients. The proposed mechanisms for spontaneous 
reduction in coronary blood flow in patients with unstable 
angina include mechanical obstruction of the atherosclerotic 
epicardial coronary arteries by labile thrombus or platelet 
aggregates and dynamic reversible increase in arterial tone 
mediated by vasoactive substances (12). Whatever the 
mechanisms might be, they are likely to be similar for both 
symptomatic and asymptomatic ischemia. 
Prognosis of silent ischemia. Is the prognosis of patients 
with silent ischemia any different from that of patients with 
manifest ischemia? That recurrence of angina after acute 
myocardial infarction (postinfarction angina) is associated 
with unfavorable prognosis has been well documented (13). 
“Silent ischemia” in patients after infarction is also associ- 
ated with a poorer prognosis (14). An unfavorable 1 and 6 
month prognosis in the presence of silent ST segment shifts 
in patients with unstable angina has been reported previ- 
ously (15,16). The report of Langer et al. (7) also suggests 
that in patients with both symptomatic and asymptomatic 
unstable angina, ST shifts are associated with an in-hospital 
unfavorable outcome. Although these investigators noted 
that “more patients with recurrent chest pain associated 
with any ST shift during Holter monitoring had an unfavor- 
able outcome than did patients with an ST shift alone,” the 
difference was at best modest. Thus, it appears that at least 
in certain subsets of patients with established coronary 
artery disease, anatomic pathology, pathophysiology and 
prognosis of both silent and manifest myocardial ischemia 
are very similar. 
Treatment. Should therapeutic approach be different for 
manifest and silent ischemia? Ideally, therapy should be 
based on the knowledge of the pathophysiologic mechanisms 
of ischemia in individual patients, which, however, are 
variable in different ischemic syndromes and are not always 
apparent. Fortunately, available therapy appears to be 
equally effective for the control of both manifest and silent 
myocardial ischemia. Antianginal drugs, including nitrates, 
calcium entry blocking agents and beta-adrenergic blocking 
drugs, decrease both symptomatic and asymptomatic epi- 
sodes of ischemia. Similarly, myocardial perfusion therapy 
by angioplasty or coronary artery bypass surgery decreases 
the frequency of both symptomatic and asymptomatic ische- 
mia. Thus, from available data, it appears that the same 
therapy is effective for the control of both symptomatic and 
asymptomatic myocardial ischemia. However, as asympto- 
matic ischemia in patients with established coronary artery 
disease appears to be associated with similar consequences 
and prognosis as with symptomatic ischemia, the time has 
arrived, I believe, to direct therapeutic objectives for the 
detection and treatment of “ischemia” whether or not it 
manifests clinically or remains silent. 
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